FIELD: medicine, experimental and clinical immunology.
SUBSTANCE: hemolysate should be preincubated with unlabelled insulin at 4:1 ratio; insulin level both before and after incubation should be detected by altered optic density of the solution at 540 nm wave length.
EFFECT: higher availability and reliability of detection.
1 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIABETES MELLITUS COMPENSATION DETERMINATION IN CHILDREN | 1991 |
|
RU2022270C1 |
METHOD OF DIAGNOSIS OF DIABETES MELLITUS | 0 |
|
SU1115723A1 |
METHOD OF DETERMINING PERSONAL SENSITIVITY TO HEMOSORPTION IN DIABETES MELITIS | 0 |
|
SU1491520A1 |
METHOD FOR ASSESSING CHARACTER OF AUTOIMMUNE REACTION OF HUMAN BODY TO MULTIPLE MODIFIED LOW-DENSITY LIPOPROTEINS IN LYTIC TEST | 2017 |
|
RU2680848C1 |
RECOMBINANT PLASMID DNA pAS-2 ENCODING HUMAN BEING PROINSULIN POLYPEPTIDE Aspart AND STRAIN OF BACTERIA Escherichia coli BAS2-RECOMBINANT PROINSULIN Aspart PRODUCER | 2006 |
|
RU2337964C2 |
METHOD FOR DIAGNOSING OXIDATION STRESS IN HUMAN ORGANISM | 2003 |
|
RU2236008C1 |
SCREENING TEST FOR DETERMINING THE FUNCTIONAL ACTIVITY OF THE CLASSIC COMPLEMENT PATHWAY | 2018 |
|
RU2704121C1 |
BLOOD SELL FAGOCYTE ACTIVITY DETERMINATION METHOD | 0 |
|
SU1037177A1 |
METHOD FOR PREDICTION OF GLYCOSYLATED HAEMOGLOBIN IN PATIENTS SUFFERING FROM DIABETES MELLITUS TYPE 2 | 2013 |
|
RU2533456C1 |
METHOD FOR DIFFERENTIATION OF ADULT HUMAN STEM CELLS IN INSULIN-SECRETING CELLS | 2010 |
|
RU2430158C1 |
Authors
Dates
2004-10-27—Published
2002-07-05—Filed